Standout Papers
Citation Impact
Citing Papers
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma
2017
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
2017 Standout
Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism
2021
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
2020
Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
2013
Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment
2019
Biomarkers of response to PD-1/PD-L1 inhibition
2017
Pancreatic cancer
2020 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Macrophages in immunoregulation and therapeutics
2023 Standout
New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression
2018
The immune contexture in cancer prognosis and treatment
2017 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry
2017
Targeting tumor-associated macrophages to synergize tumor immunotherapy
2021
Finding nemo: imaging findings, pitfalls, and complications of ingested fish bones in the alimentary canal
2012
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Eicosanoids in Cancer: New Roles in Immunoregulation
2020
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Targeting macrophages in cancer immunotherapy
2021
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Gastric cancer
2020 Standout
The molecular landscape of head and neck cancer
2018 Standout
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease
2003
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
Fibroblasts as immune regulators in infection, inflammation and cancer
2021
Tumour heterogeneity and resistance to cancer therapies
2017 Standout
STAT3 in cancer: A double edged sword
2017
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Diversity and Biology of Cancer-Associated Fibroblasts
2020
Strategies in Developing Immunotherapy for Pancreatic Cancer: Recognizing and Correcting Multiple Immune “Defects” in the Tumor Microenvironment
2019
Removal of foreign bodies in the upper gastrointestinal tract in adults: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
2016 Standout
Works of Adrian Murphy being referenced
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
2016
Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation
2016
Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
2016
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
2019
Silver nitrate masquerading as a radiopaque foreign body
2007
IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma
2019
ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group.
1994
FRI0020 Preclinical development of sarilumab, the first fully human monoclonal antibody (MAB) against IL-6r alpha: utilization and value of double humanized animal model
2013
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer
2019
FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)
2019
Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade
2016